Neural Cell News 12.33 August 22, 2018 | |
| |
TOP STORYSIRT6 Deficiency Results in Developmental Retardation in Cynomolgus Monkeys Scientists generated a SIRT6-null cynomolgus monkey model using a CRISPR-Cas9-based approach. SIRT6 loss delays neuronal differentiation by transcriptionally activating the long non-coding RNA H19, and researchers were able to recapitulate this process in a human neural progenitor cell differentiation system. [Nature] Abstract | Editorial | |
| |
PUBLICATIONS(Ranked by impact factor of the journal)Genetically Engineered Human Cortical Spheroid Models of Tuberous Sclerosis To determine the developmental origin of tuber cells, the authors established human cellular models of tuberous sclerosis complex by CRISPR-Cas9-mediated gene editing of tuberous sclerosis complex 1 (TSC1) or TSC2 in human pluripotent stem cells. [Nat Med] Abstract Modeling Sporadic ALS in iPSC-Derived Motor Neurons Identifies a Potential Therapeutic Agent Using induced pluripotent stem cell (iPSC) technology to generate stem and differentiated cells retaining the patients’ full genetic information, researchers established a large number of in vitro cellular models of sporadic ALS. These models showed phenotypic differences in their pattern of neuronal degeneration, types of abnormal protein aggregates, cell death mechanisms, and onset and progression of these phenotypes in vitro among cases. [Nat Med] Abstract Using unbiased genome-scale CRISPR-Cas9 approaches to detect genes involved in tumor cell growth and survival, the authors identified 147 candidate gene dependencies selective for MYCN-amplified neuroblastoma cell lines, compared to over 300 other human cancer cell lines. [Nat Genet] Abstract Rapid and Efficient Induction of Functional Astrocytes from Human Pluripotent Stem Cells Researchers demonstrated that overexpression of the transcription factors SOX9 and NFIB in human pluripotent stem cells rapidly and efficiently yields homogeneous populations of induced astrocytes. [Nat Methods] Abstract | Press Release Scientists used human-induced pluripotent stem cells (iPSC) and their neural derivatives to characterize common variants on chromosome 3p22 that have been associated by genome-wide association studies with major mental illnesses. [Mol Psychiatry] Abstract Investigators report that expression of the mouse homolog of Drosophila tumor suppressor lethal giant larvae 1 (Lgl1) is induced during oligodendrocyte (OL) differentiation. Lgl1 conditional knockout oligodendrocyte progenitor cells progeny retained NG2 and showed reduced OL differentiation, while undergoing more symmetric self-renewing divisions at the expense of asymmetric divisions. [Nat Commun] Full Article 3D Printed Stem‐Cell Derived Neural Progenitors Generate Spinal Cord Scaffolds Successful bioprinting of oligodendrocyte progenitor cells in combination with spinal neuronal progenitor cells demonstrated a multicellular neural tissue engineering approach, where the ability to direct the patterning and combination of transplanted neuronal and glial cells can be beneficial in rebuilding functional axonal connections across areas of central nervous system tissue damage. [Adv Funct Mater] Abstract The authors revealed advillin expression restricted to isolectin B4-positive (IB4+) neurons in the adult dorsal root ganglia (DRG). Advillin knockout specifically impaired axonal regeneration in adult IB4+ DRG neurons. [Proc Natl Acad Sci USA] Full Article Regulation of Protective Autophagy in Anoikis-Resistant Glioma Stem Cells by SDCBP/MDA-9/Syntenin In nonadherent conditions, glioma stem cells displayed protective autophagy and anoikis-resistance, which correlated with expression of SDCBP/MDA-9/Syntenin. When SDCBP/MDA-9/Syntenin was absent, this protective mechanism was deregulated, leading to highly elevated and sustained levels of autophagy and consequently decreased cell survival. [Autophagy] Abstract Performing in vivo laser axotomies in C. elegans, investigators found that neuronal regeneration is substantially increased by disruptions of either the O-linked β-N-acetylglucosamine (O-GlcNAc) transferase or the O-GlcNAcase that decrease and increase O-GlcNAc levels, respectively. [Cell Rep] Full Article | Graphical Abstract Scientists report that living neurons with tau inclusions from P301S-tau mice exposed abnormally high amounts of phosphatidylserine because of the production of reactive oxygen species. Consequently, co-cultured phagocytes identified and phagocytosed the living neurons, thereby engulfing insoluble tau inclusions. [Cell Rep] Full Article | Graphical Abstract Subscribe to one of our other 19 science newsletters such as Cancer Stem Cell News & ESC & iPSC News. | |
| |
REVIEWSC9orf72-Mediated ALS and FTD: Multiple Pathways to Disease The authors review the pathological and mechanistic features of C9orf72-associated frontotemporal dementia (FTD) and ALS, the model systems used to study these conditions, and the probable initiators of downstream disease mechanisms. [Nat Rev Neurol] Abstract Visit our reviews page to see a complete list of reviews in the neural cell research field. | |
| |
INDUSTRY NEWSA New Research Partnership to Find Treatments for Neurological Disorders BioMotiv and Cure Network Dolby Acceleration Partners have entered into an agreement to develop small molecules that could provide new treatment options for patients with neurological disorders, such as Dravet syndrome, other epilepsies, and Alzheimer’s disease. [BioMotiv] Press Release £1.5M Boost for Brain Tumor Research Cancer experts at Edinburgh have received £1.5 million for research to better understand brain tumors. [University of Edinburgh] Press Release AIVITA Biomedical Announces Initiation of First Clinical Site for ROOT OF CANCER Glioblastoma Trial AIVITA Biomedical announced the initiation of its first clinical site for the company’s ROOT OF CANCER Phase II trial in patients with newly diagnosed glioblastoma. [AIVITA Biomedical] Press Release ProMIS Neurosciences, Inc. announced that its lead antibody candidate for Alzheimer’s disease (AD), PMN310, showed no binding to amyloid beta (Aβ) plaque in AD brain samples in stark contrast to BAN2401 and aducanumab which both displayed robust Aβ plaque reactivity. [ProMIS Neurosciences, Inc.] Press Release Y-mAbs Therapeutics, Inc. announced that the company has received a Breakthrough Therapy designation for naxitamab, in combination with GM-CSF, for the treatment of high risk neuroblastoma refractory to initial therapy or with incomplete response to salvage therapy in patients older than 12 months of age with persistent, refractory disease limited to bone marrow with or without evidence of concurrent bone involvement. [Y-mAbs Therapeutics, Inc.] Press Release AC Immune SA announced two clinical milestone events related to ACI-24, its anti-Abeta vaccine against Alzheimer’s disease and Abeta-related cognitive decline in Down syndrome. [AC Immune SA] Press Release | |
| |
POLICY NEWSIn Defiance of Trump’s Budget, Senate Poised to Boost NIH Funding—Again Ignoring President Donald Trump’s proposed budget, the Senate is setting up to approve a $2 billion boost in funding for the National Institutes of Health (NIH). [Fierce Biotech] Editorial Hundreds of Chimps at the NIH Await Retirement. This Senator Wants to Help Sen. Bill Cassidy is trying to help hundreds of chimpanzees enjoy an easy retirement in his home state of Louisiana. The Republican is pushing for an amendment to a major appropriations bill winding its way through Congress that would force the National Institutes of Health (NIH) to make good on a 2015 promise to move all its chimps out of research facilities. [STAT News] Editorial Chief of Europe’s €1-Billion Brain Project Steps Down The executive director of the European Union’s ambitious — but contentious — Human Brain Project has left his post after a disagreement with the institution that coordinates the initiative. [Nature News] Editorial
| |
EVENTSNEW Epigenetics in the Nervous System: Development and Disease Visit our events page to see a complete list of events in the community.
| |
JOB OPPORTUNITIESNEW Tenure Eligible Investigator – Neurobiology (Universite Bourgogne Franche-Comté) Postdoctoral Position – Stem Cell-Based Modeling of Psychiatric Disease (Universitat Bonn) Excellence in Science PhD Scholarship Award – Neuroscience (University of Technology Sydney) Scientist/Assistant Professor – Neuroscience (The Hospital for Sick Children) Postdoctoral Associate – Cerebral Organoids (Weill Cornell Medicine) Postdoctoral Associate – hiPSC-Based Brain Organoids (Rutgers University) Multiple Faculty Positions – Neuroscience and Neuroengineering (Tsinghua University) Faculty Members – Neuroscience (Mercer University) Recruit Top Talent: Reach potential candidates by posting your organization’s career opportunities on the Connexon Creative Job Board at no cost.
| |
Have we missed an important article or publication in Neural Cell News? Click here to submit! Comments or suggestions? Submit your feedback here. | |
|